Advancing Parkinson’s disease biopathology and drug discovery by dual cellular modelling
Authors:
- PinFen ChuaPCPinFen Chua
- Nurr Maria Ulfa SerujiNSNurr Maria Ulfa Seruji
- Mas Atikah LizazmanMLMas Atikah Lizazman
- Vivien Yi Mian JongVJVivien Yi Mian Jong
- William K. LimWilliam K. Lim
Open Access
- 1 December 2024
- journal article
- research article
- Published by Scientific Scholar in Journal of King Saud University – Science
- Vol. 36 (11)
Abstract
No abstract availableKeywords
All Related Versions
This publication has 35 references indexed in Scilit:
- The strategic uses of collagen in adherent cell culturesCell Biology International, 2022
- AMPK-dependent autophagy activation and alpha-Synuclein clearance: a putative mechanism behind alpha-mangostin’s neuroprotection in a rotenone-induced mouse model of Parkinson’s diseaseMetabolic Brain Disease, 2022
- Apoptosis and its therapeutic implications in neurodegenerative diseasesClinical Anatomy, 2021
- The Discovery of α‐Synuclein in Lewy Pathology of Parkinson's Disease: The Inspiration of a RevolutionMovement Disorders Clinical Practice, 2021
- 6-Hydroxydopamine: a far from simple neurotoxinJournal of Neural Transmission, 2020
- An In Vitro Oxygen–Glucose Deprivation Model for Studying Ischemia–Reperfusion Injury of Neuronal Cells2018
- Mimicking Parkinson’s Disease in a Dish: Merits and Pitfalls of the Most Commonly used Dopaminergic In Vitro ModelsNeuroMolecular Medicine, 2017
- Neuropathological basis of nonmotor manifestations of Parkinson's diseaseMovement Disorders, 2016
- Classic toxin-induced animal models of Parkinson?s disease: 6-OHDA and MPTPCell and tissue research, 2004
- 6-hydroxy-dopamine induced degeneration of central monoamine neuronsEuropean Journal of Pharmacology, 1968